Overview
Inpart provides an end-to-end platform for biopharma R&D teams to discover, evaluate, and manage partnerships with academia, startups, and research institutes. Its tools like Deal CRM and Connect matchmaking streamline opportunity tracking, dealmaking, and scouting campaigns. Used by over 6,500 companies including 45 of the top 50 global pharma firms, it accelerates innovation pipelines through data unification and expert curation.
Frequently asked questions
- What capabilities does Inpart offer for biopharma R&D partnering?
- Inpart offers Deal CRM for centralizing partnering data and opportunity tracking, Connect for matchmaking with academic and startup technologies, and Campaigns for targeted scouting of proposals from global research networks.
- What industries and geographies does Inpart serve?
- Inpart serves biopharma, scientific, and academic sectors globally, connecting over 6,500 companies including top pharma firms with more than 200 leading universities and a network of startups and SMEs worldwide.
- How does Inpart ensure regulatory and data security compliance?
- Inpart provides secure, integrated platforms with structured data intake, intelligent syncing, and collaboration tools designed for biopharma, used by top R&D-intensive firms without mention of specific regulatory certifications in available details.